Dopamine: The Currency of Desire
Rethinking the “pleasure molecule” could help scientists better understand addiction, Parkinson’s disease and motivation
We use cookies to provide you with a better onsite experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Rethinking the “pleasure molecule” could help scientists better understand addiction, Parkinson’s disease and motivation
Don’t worry about disobedient machines. Devious human masters and misunderstood commands are the real threat
Brain scans may offer clues to a person’s natural aptitude—and help those less gifted learn how to study better
Magicians and cognitive scientists know how to manipulate what we pick—or thought we picked
A decades-long study of exceptionally gifted children reveals what it takes to hone the world's sharpest minds
Gordon Briggs, a postdoc at the U.S. Naval Research Laboratory, talks about the article he and Matthias Scheutz, director of the Human Robot Interaction Laboratory at Tufts University, wrote in the January issue of Scientific American titled the Case for Robot Disobedience.
Research shows that maintaining eye contact can make it harder to think
Science has long debated whether meeting another’s gaze feels unpleasant or just uninteresting
Researchers are focusing on a way to disrupt frightening memories of spiders
Hearing a foreign language in the background can help you learn it faster, even if you are not paying attention
A study of white female nurses found those who were more optimistic were a third less likely to die of any cause
A look inside the January/February issue of Scientific American Mind
They can solve puzzles that solitary leopards and tigers can’t—evidence that sociality promotes high-level cognition
Whistles let shepherds communicate between distant hillsides because a whistled sound wave travels farther than spoken words.
A 2010 study claimed that striking certain poses could alter hormone levels and risk-taking behavior. But subsequent studies can’t replicate that finding. Christopher Intagliata reports.
Several “artificial” approaches exist but most evidence suggests that training cannot capture a synesthete’s experience
Johns Hopkins clinical pharmacologist Roland Griffiths talks about a major new study hinting at psychedelic drugs as therapeutic powerhouses
The drug, and others based on the “amyloid hypothesis,” are still being tested in other, different trials
Scientists are discovering how the brain navigates

Give a year of Scientific American MIND, get our 2017 Hubble Telescope Calendar Free!